Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Can demographic and anthropometric characteristics predict clinical improvement in patients with chronic non-specific low back pain?

Oliveira IS, Costa LOP, Garcia AN, Miyamoto GC, Cabral CMN, Costa LDCM.

Braz J Phys Ther. 2018 Jun 28. pii: S1413-3555(17)30554-3. doi: 10.1016/j.bjpt.2018.06.005. [Epub ahead of print]

PMID:
30017258
2.

Cost-effectiveness of exercise therapy in the treatment of non-specific neck pain and low back pain: a systematic review with meta-analysis.

Miyamoto GC, Lin CC, Cabral CMN, van Dongen JM, van Tulder MW.

Br J Sports Med. 2018 Apr 20. pii: bjsports-2017-098765. doi: 10.1136/bjsports-2017-098765. [Epub ahead of print] Review.

PMID:
29678893
3.

Different doses of Pilates-based exercise therapy for chronic low back pain: a randomised controlled trial with economic evaluation.

Miyamoto GC, Franco KFM, van Dongen JM, Franco YRDS, de Oliveira NTB, Amaral DDV, Branco ANC, da Silva ML, van Tulder MW, Cabral CMN.

Br J Sports Med. 2018 Jul;52(13):859-868. doi: 10.1136/bjsports-2017-098825. Epub 2018 Mar 10.

PMID:
29525763
4.

Three-dimensional observations of morphology of low-angle boundaries in ultra-low carbon lath martensite.

Morito S, Hoang Pham A, Ohba T, Hayashi T, Furuhara T, Miyamoto G.

Microscopy (Oxf). 2017 Dec 1;66(6):380-387. doi: 10.1093/jmicro/dfx027.

PMID:
28992228
5.

Is Interferential Current Before Pilates Exercises More Effective Than Placebo in Patients With Chronic Nonspecific Low Back Pain?: A Randomized Controlled Trial.

Franco KM, Franco YD, Oliveira NB, Miyamoto GC, Santos MO, Liebano RE, Cabral CN.

Arch Phys Med Rehabil. 2017 Feb;98(2):320-328. doi: 10.1016/j.apmr.2016.08.485. Epub 2016 Oct 19.

PMID:
27771359
6.

Effectiveness and Cost-Effectiveness of Different Weekly Frequencies of Pilates for Chronic Low Back Pain: Randomized Controlled Trial.

Miyamoto GC, Moura KF, Franco YR, Oliveira NT, Amaral DD, Branco AN, Silva ML, Lin C, Cabral CM.

Phys Ther. 2016 Mar;96(3):382-9. doi: 10.2522/ptj.20150404. Epub 2015 Aug 20.

PMID:
26294680
7.

Efficacy of the addition of interferential current to Pilates method in patients with low back pain: a protocol of a randomized controlled trial.

Franco YR, Liebano RE, Moura KF, de Oliveira NT, Miyamoto GC, Santos MO, Cabral CM.

BMC Musculoskelet Disord. 2014 Dec 10;15:420. doi: 10.1186/1471-2474-15-420.

8.

Efficacy of the Pilates method for pain and disability in patients with chronic nonspecific low back pain: a systematic review with meta-analysis.

Miyamoto GC, Costa LO, Cabral CM.

Braz J Phys Ther. 2013 Nov-Dec;17(6):517-32. doi: 10.1590/S1413-35552012005000127. Review. English, Portuguese.

9.

Efficacy of the addition of modified Pilates exercises to a minimal intervention in patients with chronic low back pain: a randomized controlled trial.

Miyamoto GC, Costa LO, Galvanin T, Cabral CM.

Phys Ther. 2013 Mar;93(3):310-20. doi: 10.2522/ptj.20120190. Epub 2012 Oct 11.

PMID:
23064732
11.

Microstructures and mechanical properties of metastable Ti-30Zr-(Cr, Mo) alloys with changeable Young's modulus for spinal fixation applications.

Zhao X, Niinomi M, Nakai M, Miyamoto G, Furuhara T.

Acta Biomater. 2011 Aug;7(8):3230-6. doi: 10.1016/j.actbio.2011.04.019. Epub 2011 Apr 27.

PMID:
21569873
12.

Carrier-mediated uptake of grepafloxacin, a fluoroquinolone antibiotic, by the isolated rat lung cells.

Sasabe H, Kato Y, Suzuki T, Itose M, Miyamoto G, Sugiyama Y.

Drug Metab Pharmacokinet. 2005 Dec;20(6):491-5.

13.

High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: application to the pharmacokinetic study.

Shimokawa Y, Akiyama H, Kashiyama E, Koga T, Miyamoto G.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):8-14.

PMID:
15897016
14.

Effect of gamma-oryzanol on cytochrome P450 activities in human liver microsomes.

Umehara K, Shimokawa Y, Miyamoto G.

Biol Pharm Bull. 2004 Jul;27(7):1151-3.

15.

Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice.

Sasabe H, Kato Y, Suzuki T, Itose M, Miyamoto G, Sugiyama Y.

J Pharmacol Exp Ther. 2004 Aug;310(2):648-55. Epub 2004 May 6.

16.

Oxidative one-carbon cleavage of the octyl side chain of olanexidine, a novel antimicrobial agent, in dog liver microsomes.

Umehara K, Shimokawa Y, Koga T, Ohtani T, Miyamoto G.

Xenobiotica. 2004 Jan;34(1):61-71.

PMID:
14742137
17.

The pharmacokinetics of toborinone in subjects with congestive heart failure and concomitant renal impairment and/or concomitant hepatic impairment.

Tammara B, Trang JM, Kitani M, Miyamoto G, Bramer SL.

J Clin Pharmacol. 2002 Dec;42(12):1318-25.

PMID:
12463726
18.

Mechanism for the tissue distribution of grepafloxacin, a fluoroquinolone antibiotic, in rats.

Suzuki T, Kato Y, Sasabe H, Itose M, Miyamoto G, Sugiyama Y.

Drug Metab Dispos. 2002 Dec;30(12):1393-9.

19.

Effect of probucol on cytochrome P450 activities in human liver microsomes.

Umehara K, Shimokawa Y, Miyamoto G.

Biol Pharm Bull. 2002 Aug;25(8):1112-4.

20.

Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver.

Koyama N, Sasabe H, Miyamoto G.

Xenobiotica. 2002 Jul;32(7):573-86.

PMID:
12162853
21.

Local gastric and serum concentrations of rebamipide following oral ingestion in healthy volunteers.

Akamatsu T, Nakamura N, Furuya N, Shimizu T, Gotou A, Kiyosawa K, Katsuyama T, Osumi T, Hirao Y, Miyamoto G.

Dig Dis Sci. 2002 Jun;47(6):1399-404.

PMID:
12064818
22.

Inhibition of human drug metabolizing cytochrome P450 by buprenorphine.

Umehara K, Shimokawa Y, Miyamoto G.

Biol Pharm Bull. 2002 May;25(5):682-5.

23.

The effects of concomitant administration of theophylline and toborinone on the pharmacokinetics of both compounds in poor and extensive metabolizers via CYP2D6.

Tammara B, Trang JM, Miyamoto G, Kitani M, Brisson J, Bramer SL.

J Clin Pharmacol. 2002 May;42(5):492-500.

PMID:
12017343
24.

Fluoroquinolone concentrations in plasma, urine, and bile after oral administration in rats with renal failure: useful technique for long-term bile collection.

Mizuta K, Hishikawa S, Hirota M, Miyamoto G, Fujimura A, Hakamata Y, Kobayashi E.

J Med. 2001;32(5-6):311-20.

PMID:
11958277
25.

In vitro characterization of the oxidative cleavage of the octyl side chain of olanexidine, a novel antimicrobial agent, in dog liver microsomes.

Umehara K, Kudo S, Hirao Y, Morita S, Ohtani T, Uchida M, Miyamoto G.

Drug Metab Dispos. 2000 Dec;28(12):1417-24.

26.

Oxidative cleavage of the octyl side chain of 1-(3,4-dichlorobenzyl)-5-octylbiguanide (OPB-2045) in rat and dog liver preparations.

Umehara K, Kudo S, Hirao Y, Morita S, Uchida M, Odomi M, Miyamoto G.

Drug Metab Dispos. 2000 Aug;28(8):887-94.

27.

Phenacetin deacetylase activity in human liver microsomes: distribution, kinetics, and chemical inhibition and stimulation.

Kudo S, Umehara K, Hosokawa M, Miyamoto G, Chiba K, Satoh T.

J Pharmacol Exp Ther. 2000 Jul;294(1):80-8.

28.

Proteases involved in the metabolic degradation of human interleukin-1beta by rat kidney lysosomes.

Kudo S, Miyamoto G, Kawano K.

J Interferon Cytokine Res. 1999 Apr;19(4):361-7.

PMID:
10334387
29.

Cytochrome P-450 isoforms involved in carboxylic acid ester cleavage of Hantzsch pyridine ester of pranidipine.

Kudo S, Okumura H, Miyamoto G, Ishizaki T.

Drug Metab Dispos. 1999 Feb;27(2):303-8.

30.
31.

Metabolism of 1-(3,4-dichlorobenzyl)-5-octylbiguanide in the dog.

Kudo S, Umehara K, Morita S, Uchida M, Miyamoto G, Odomi M.

Xenobiotica. 1998 May;28(5):507-14.

PMID:
9622852
32.

Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates.

Kitani M, Miyamoto G, Nagasawa M, Yamada T, Matsubara J, Uchida M, Odomi M.

Drug Metab Dispos. 1997 Jun;25(6):663-74.

33.

Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid.

Miyamoto G, Zahid N, Uetrecht JP.

Chem Res Toxicol. 1997 Apr;10(4):414-9.

PMID:
9114978
34.
35.

Pharmacokinetics of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3-dioxolane]platinum(II) in rats.

Cho YB, Kim DK, Kim KH, Miyamoto G.

Arzneimittelforschung. 1996 Jun;46(6):629-34.

PMID:
8767356
36.

[Induction of protective immune responses by a chimeric soluble protein from a recombinant BCG vector candidate vaccine to HIV-1].

Honda M, Kitamura K, Okamoto Y, Watanabe K, Yoshizaki H, Fukushima Y, Naganawa S, Miyamoto G, Someya K, Yamada K, et al.

Rinsho Ketsueki. 1995 May;36(5):435-41. Japanese.

PMID:
7783347
37.

Pharmacokinetics and pharmacodynamics of intravenous OPC-18790 in humans: a novel nonglycosidic inotropic agent.

Ohnishi A, Toyoki T, Ohno T, Takeshige Y, Fujita T, Kodama K, Mishima M, Hirayama A, Kitani M, Miyamoto G, et al.

J Clin Pharmacol. 1994 Feb;34(2):176-83.

PMID:
8163718
38.
39.

[Case of post-transfusion hepatitis B complicated with Guillain-Barré syndrome].

Nakano A, Mori H, Kanda T, Miyamoto G, Sato T, Shimizu Y, Hazama K.

Nihon Naika Gakkai Zasshi. 1993 Oct 10;82(10):1720-1. Japanese. No abstract available.

PMID:
8228471
40.

Pharmacokinetics, safety, and pharmacologic effects of OPC-21268, a nonpeptide orally active vasopressin V1 receptor antagonist, in humans.

Ohnishi A, Ko Y, Fujihara H, Miyamoto G, Okada K, Odomi M.

J Clin Pharmacol. 1993 Mar;33(3):230-8.

PMID:
8385161
41.
45.

High-performance liquid chromatographic procedure for the determination of probucol in human plasma.

Kudo S, Akiyama H, Odomi M, Miyamoto G.

J Chromatogr. 1983 Oct 14;277:419-22. No abstract available.

PMID:
6643632
46.

Pharmacokinetics of procaterol in the rat, rabbit and beagle dog.

Ishigami M, Saburomaru K, Niino K, Kido M, Morita S, Miyamoto G, Kohri H.

Arzneimittelforschung. 1979;29(2):266-70. No abstract available.

PMID:
36108
47.

The metabolism of a bronchodilator procaterol HCL in the rat in vitro and in vivo.

Shimizu T, Mori H, Tabusa E, Morita S, Miyamoto G, Yasuda Y, Nakagawa K.

Xenobiotica. 1978 Jun;8(6):349-58.

PMID:
676342
48.

[Proceedings: Tetralogy of Fallot associated with idiopathic hypertrophic subvalvular stenosis--a surgical case].

Miyamoto G, Kawashima K, Horiguchi Y, Danno M, Hashimoto S.

Jpn Circ J. 1975 Jul;39(7):350-1. Japanese. No abstract available.

PMID:
1171998

Supplemental Content

Loading ...
Support Center